Acetaminophen 500 mg

Description

The drug is identified as apap-500-mg-red, with an effective date of October 26, 2022. An image reference for the drug is available as apap-500-mg-red.jpg.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Healthcare professionals should refer to the prescribing information for detailed indications and usage.

Limitations of use and any potential teratogenic or nonteratogenic effects have not been specified in the provided information. It is essential for healthcare providers to evaluate the appropriateness of this drug based on individual patient circumstances and existing clinical data.

Dosage and Administration

The active ingredient in this formulation is acetaminophen, with a dosage of 500 mg. This medication is to be administered orally.

Healthcare professionals should ensure that patients are instructed to take the medication as directed, adhering to the recommended dosing guidelines. It is essential to monitor the frequency of administration to avoid exceeding the maximum daily dosage.

Patients should be advised to take the medication with a full glass of water, and it may be taken with or without food, depending on individual tolerance. Proper patient education regarding the importance of following the prescribed dosage and administration schedule is crucial for optimal therapeutic outcomes.

Contraindications

There are no specified contraindications for the use of this product. Healthcare professionals should exercise clinical judgment and consider individual patient circumstances when determining the appropriateness of this product for their patients.

Warnings and Precautions

Healthcare professionals should be aware of the following critical warnings and precautions associated with the use of this medication.

It is essential to monitor patients closely for any adverse reactions or complications that may arise during treatment. Regular laboratory tests may be necessary to assess the patient's response to therapy and to ensure safety. Specific monitoring parameters should be established based on the individual patient's health status and the medication's profile.

In the event of severe side effects or unexpected reactions, immediate medical attention should be sought. Healthcare providers should instruct patients to discontinue use and contact their physician if they experience any concerning symptoms.

Overall, a thorough understanding of the potential risks and the implementation of appropriate monitoring strategies are vital for the safe administration of this medication.

Side Effects

Severe liver damage may occur if patients exceed the recommended dose. Therefore, it is crucial to adhere to dosing guidelines to mitigate the risk of overdose, which can lead to fatal liver failure.

Common adverse reactions observed in clinical trials include nausea, vomiting, stomach pain, loss of appetite, and headache. These reactions were reported with varying frequencies among participants.

Less common adverse reactions include allergic reactions such as skin rash, itching, or swelling, as well as liver function abnormalities. Patients should be monitored for these less frequent but significant reactions.

Rare adverse reactions have also been reported, including severe allergic reactions like anaphylaxis and serious skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.

It is advised to use this medication with caution in patients with pre-existing liver disease or those who engage in heavy alcohol use, as these factors may exacerbate the risk of adverse effects.

Drug Interactions

There are no specific drug interactions identified in the available data. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Acetaminophen 500 mg (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use of acetaminophen is generally considered safe when used as directed. The dosage for children is typically based on weight and age. For children aged 2 to 12 years, the recommended dosing is 10-15 mg/kg every 4 to 6 hours as needed, with a maximum of 5 doses in a 24-hour period. For children under 2 years of age, it is essential to consult a healthcare professional for appropriate dosing.

Special precautions should be taken to avoid overdose, as acetaminophen can cause severe liver damage. Parents and caregivers are advised to use the measuring device provided with the medication to ensure accurate dosing. It is also important to check with a healthcare provider before administering acetaminophen to children, particularly if they have underlying health conditions or are taking other medications.

Geriatric Use

Elderly patients do not have specific geriatric use considerations, dosage adjustments, safety concerns, or special precautions associated with Acetaminophen 500 mg as indicated in the prescribing information. Therefore, standard dosing guidelines may be applied without modification for this population. However, healthcare providers should continue to monitor elderly patients for any potential adverse effects, as individual responses to medication can vary.

Pregnancy

Safety during pregnancy has not been established for this medication. There may be potential risks to the fetus; therefore, it is essential for pregnant patients to consult a healthcare provider before use.

Dosage adjustments may be necessary for women of childbearing potential who are pregnant, and medical advice should be sought to determine the appropriate dosing during this period. Use of this medication is contraindicated in pregnancy unless clearly needed and prescribed by a healthcare professional.

Lactation

There is no specific information available regarding the use of Acetaminophen 500 mg in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers on the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

Overdosage of acetaminophen can result in significant hepatic injury. Healthcare professionals should be vigilant in recognizing the signs and symptoms associated with acetaminophen overdosage, which may manifest as nausea, vomiting, loss of appetite, confusion, and jaundice.

In the event of suspected overdosage, it is imperative to seek immediate medical attention. Prompt intervention is crucial to mitigate the risk of severe liver damage.

Management of acetaminophen overdosage typically involves the administration of activated charcoal, which may help reduce absorption if given shortly after ingestion. Additionally, N-acetylcysteine is recommended as an antidote and should be administered as soon as possible to enhance the likelihood of a favorable outcome.

Nonclinical Toxicology

No teratogenic effects were observed in animal studies. Additionally, there was no increase in fetal malformations noted in these studies. The available data do not indicate any concerns regarding teratogenicity or non-teratogenic effects in the context of animal testing.

Information regarding animal pharmacology and toxicology is not provided in the insert.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to use acetaminophen only as directed on the package or by a healthcare professional. It is important to emphasize that they must not exceed the recommended dose of acetaminophen, as doing so may lead to serious health risks.

Healthcare providers should inform patients about the potential risk of liver damage associated with exceeding the recommended dose or consuming alcohol while taking acetaminophen. Patients with liver disease or those who consume three or more alcoholic drinks daily should be encouraged to consult a healthcare professional before using this medication.

Additionally, patients should be instructed to seek immediate medical attention if they experience symptoms of an allergic reaction, which may include rash, itching or swelling, or difficulty breathing.

Finally, it is crucial to remind patients to keep this and all other medications out of the reach of children and to never share their medicines with others, ensuring safe medication practices.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light to ensure its stability. Once opened, the product should be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Acetaminophen 500 mg, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)